ORIENT BIO Inc. (KRX:002630)

South Korea flag South Korea · Delayed Price · Currency is KRW
597.00
-11.00 (-1.81%)
Mar 3, 2026, 3:33 PM KST
-64.65%
Market Cap 69.96B
Revenue (ttm) 59.09B
Net Income (ttm) -6.85B
Shares Out 118.57M
EPS (ttm) -57.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,773,014
Average Volume 5,512,007
Open 588.00
Previous Close 608.00
Day's Range 574.00 - 619.00
52-Week Range 513.00 - 2,560.00
Beta 0.14
RSI 48.46
Earnings Date n/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1959
Employees 125
Stock Exchange Korea Stock Exchange
Ticker Symbol 002630
Full Company Profile

Financial Performance

In fiscal year 2021, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2020.

Financial Statements

News

There is no news available yet.